Compound Detail
CHEMBL356359
PIBOSEROD 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL356359 |
| Name | PIBOSEROD |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | KVCSJPATKXABRQ-UHFFFAOYSA-N |
2
Targets
11
Activities
2
Assay Types
4
PK Parameters
20
Publications
2
Known Names
2
Indications
1
Mechanisms
Molecular Properties
369.5
MW (Da)
3.67
ALogP
4
HBA
1
HBD
46.5
PSA (Ų)
0.85
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Serotonin 4 (5-HT4) receptor antagonist | ANTAGONIST | 5-hydroxytryptamine receptor 4 | ✓ | ✓ |
Indications
Atrial Fibrillation Heart Failure
Activity Summary
Ki 10 meas. best 10.28
IC50 1 meas. best 9.2
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 4 CHEMBL1875 | Ki | 10.28 | 9.6089 | 0.1 | 9 |
| 5-hydroxytryptamine receptor 4 CHEMBL1875 | IC50 | 9.2 | 9.2 | 0.6 | 1 |
| 5-hydroxytryptamine receptor 4 CHEMBL5017 | Ki | 8.8 | 8.8 | 1.6 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 8.0 | mL.min-1.kg-1 | Canis lupus familiaris |
| F | 71.0 | % | Canis lupus familiaris |
| T1/2 | 7.1 | hr | Canis lupus familiaris |
| Vd | 5.0 | L.kg-1 | Canis lupus familiaris |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 15745824 | 10.1016/j.bmcl.2005.01.039 | ADMET | 6 |
| 24113240 | 10.1016/j.bmc.2013.09.004 | 5-hydroxytryptamine receptor 4 | 4 |
| 23043420 | 10.1021/jm300573d | 5-hydroxytryptamine receptor 4 | 4 |
| 7490724 | 10.1021/jm00024a002 | 5-hydroxytryptamine receptor 4 | 2 |
| 23711770 | 10.1016/j.ejmech.2013.03.060 | 5-hydroxytryptamine receptor 4 | 2 |
| 25149506 | 10.1016/j.bmcl.2014.06.083 | 5-hydroxytryptamine receptor 4 | 2 |
| 21075638 | 10.1016/j.bmc.2010.10.011 | 5-hydroxytryptamine receptor 4 | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 7490724 | 10.1021/jm00024a002 | D(2) dopamine receptor | 1 |
| 7490724 | 10.1021/jm00024a002 | Histamine H1 receptor | 1 |
| 15745824 | 10.1016/j.bmcl.2005.01.039 | 5-hydroxytryptamine receptor 4 | 1 |
| 7490724 | 10.1021/jm00024a002 | Unchecked | 1 |
| 19261477 | 10.1016/j.bmc.2008.11.045 | 5-hydroxytryptamine receptor 3A | 1 |
| 21075638 | 10.1016/j.bmc.2010.10.011 | No relevant target | 1 |
| 7490724 | 10.1021/jm00024a002 | 5-hydroxytryptamine receptor 2A | 1 |
| 7490724 | 10.1021/jm00024a002 | 5-hydroxytryptamine receptor 1E | 1 |
| 7490724 | 10.1021/jm00024a002 | 5-hydroxytryptamine receptor 1D | 1 |
| 7490724 | 10.1021/jm00024a002 | 5-hydroxytryptamine receptor 1A | 1 |
Data from ChEMBL 36 via Core Engine